Melanotan II (MT-2) 10 mg

Melanocortin Receptor Agonist

In plain terms: This compound acts on the same receptor system that governs skin

pigmentation and appetite signaling. Research has tracked pigmentation changes and

appetite-related markers in study subjects.

Compound classification: Melanotan II is a synthetic analog of alpha-MSH studied in

relation to melanocortin receptor activity.

Studied mechanism: Research has examined MT-2 activity at MC1R (pigmentation-

related) and MC4R (appetite/energy-related) receptors.

Research findings: Published research has documented pigmentation changes,

appetite-related markers, and central-nervous-system-mediated parameters in study

models.

Effects reported in research literature:

Nausea

Flushing

Increased pigmentation, including freckles and moles

Research status: Response variability across study subjects has been noted in the

literature; excessive receptor activation has been associated with uneven pigmentation

outcomes in research settings.

Research Use Only: This compound is intended for laboratory research use only. It is

not a drug, dietary supplement, or consumer product, and is not for human or animal

consumption. Statements have not been evaluated by the FDA and are not intended to

diagnose, treat, cure, or prevent any disease.